Home › Funds › Sands Capital Alternatives, LLC › CADL

Sands Capital Alternatives, LLC position in CADL

CANDEL THERAPEUTICS INC · Health Care

Sands Capital Alternatives, LLC reported holding 405,837 shares of CADL (CANDEL THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$4.2M, representing 0.63% of its reported portfolio and ranking #22 among its reported holdings. Sands Capital Alternatives, LLC has disclosed CADL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)405.84K sh
Reported value held$4.24M
Portfolio Weight0.63%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Sands Capital Alternatives, LLC's CADL position evolved

Sands Capital Alternatives, LLC first disclosed a stake in CADL in Q3 2023 at 811,737 shares (US$747K). The position peaked in Q3 2026 at 405,837 shares, worth US$4.2M. Across 13 filings, Sands Capital Alternatives, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 405,837 shares valued at US$4.2M. Notable position changes include a 50% trim in Q2 2024 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 811.74K $746.80K New
Q4 2023 811.74K $1.19M Hold
Q1 2024 811.74K $1.28M Hold
Q2 2024 405.84K $2.52M Reduce
Q3 2024 405.84K $2.81M Hold
Q4 2024 405.84K $3.52M Hold
Q1 2025 405.84K $2.29M Hold
Q2 2025 405.84K $2.05M Hold
Q3 2025 405.84K $2.07M Hold
Q4 2025 405.84K $2.29M Hold
Q1 2026 405.84K $1.99M Hold
Q2 2026 405.84K $4.18M Hold
Q3 2026 405.84K $4.24M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CADL and 13F data

CADL (CANDEL THERAPEUTICS INC) is a Health Care company. 78 other funds we track also report a position in CADL — the largest reported positions include RTW INVESTMENTS, LP (US$66.1M), ACORN CAPITAL ADVISORS, LLC (US$36.0M), Portolan Capital Management, LLC (US$36.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CADL

All CADL fund holders →

FAQ

How long has Sands Capital Alternatives, LLC held CADL?

Sands Capital Alternatives, LLC has disclosed CADL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Sands Capital Alternatives, LLC's current position in CADL?

As of Q3 2026, Sands Capital Alternatives, LLC holds 405.84K shares of CADL (CANDEL THERAPEUTICS INC), valued at $4.24M, representing 0.63% of its reported portfolio and ranking #22.

Has Sands Capital Alternatives, LLC been buying or selling CADL?

In the latest 13F filing (Q3 2026), Sands Capital Alternatives, LLC held unchanged its position in CADL. The position peaked in Q3 2026 at 405.84K shares.

Which other funds hold CADL?

Other major institutional holders of CADL include RTW INVESTMENTS, LP, ACORN CAPITAL ADVISORS, LLC, Portolan Capital Management, LLC, among 78 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.